Skip to content

Investor Readiness

Investor Readiness for Biotech Founders

Investor readiness means a biotech company can answer the questions institutional investors will ask, with a clear narrative, data that holds up, a credible development and regulatory plan, a financial model and use of funds, and an organized data room, before the first meeting rather than during diligence.

A founder walks an investor through a printed deck.

What Investors Look For

An important problem and a clear view of who pays for the solution; science that is reproducible; intellectual property that protects the product; a plan with milestones that reduce risk; a team able to deliver it; and a sensible amount of capital to reach the next value point.

Building the Materials

The investment thesis and narrative; the pitch deck; the financial model and use-of-funds plan; and a data room with the science, the intellectual property, the agreements and the corporate records. Each should tell the same story at a different depth.

Entering Negotiations From Strength

We prepare founders for diligence and term sheet negotiation, make introductions to investors where the fit is right, and help develop strategic partnerships that can run alongside a financing.

Common Questions

  • How early should a company prepare for investors?

    Several months before raising. Gaps found in preparation, such as a missing assignment of rights or an unrepeated experiment, take time to close.

  • Is a pitch deck enough?

    No. The deck opens the conversation; the data, the intellectual property position and the plan behind it decide the outcome.

Related Services

Two scientists compare results on a clipboard by a window.

Get Started

Ready to Transform Your Science into a Company?

We partner with founders and research teams committed to bringing breakthrough science to market.